A cascade of care for diabetes in the United States: Visualizing the gaps

Annals of Internal Medicine

Volumn 161, Issue 10, 2014, Pages 681-689

  Ali, Mohammed K ^a,b   Bullard, Kai McKeever ^b   Gregg, Edward W ^b   Del Rio, Carlos ^a  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK REDUCTION; SECONDARY PREVENTION; UNITED STATES; ANALYSIS; BLOOD; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; NUTRITION; PATIENT CARE;

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HUMANS; NUTRITION SURVEYS; PATIENT CARE MANAGEMENT; UNITED STATES;

EID: 84923112272     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-0019     Document Type: Article

References (56)

1. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2014. Atlanta, GA; 2014. Accessed at www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf on 29 July 2014.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36: 1033-46. [PMID: 23468086] doi: 10.2337/dc12-2625
3. Thorpe KE, Ogden LL, Galactionova K. Chronic conditions account for rise in Medicare spending from 1987 to 2006. Health Aff (Millwood). 2010;29: 718-24. [PMID: 20167626] doi: 10.1377/hlthaff.2009.0474
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993; 329: 977-86. [PMID: 8366922]
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352: 837-53. [PMID: 9742976]
6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359: 1577-89. [PMID: 18784090] doi: 10.1056/NEJMoa0806470
7. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353: 2643-53. [PMID: 16371630]
8. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317: 703-13. [PMID: 9732337]
9. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, et al; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: Results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005;165: 1410-9. [PMID: 15983291]
10. Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, et al; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy of cholesterollowering therapy in 18, 686 people with diabetes in 14 randomised trials of statins: A meta-analysis. Lancet. 2008;371: 117-25. [PMID: 18191683] doi: 10.1016/S0140-6736(08)60104-X
11. Srikanth S, Deedwania P. Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: An integrated approach. Cardiol Clin. 2005; 23: 193-210. [PMID: 15694747]
12. Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest. 2007;131: 446-52. [PMID: 17296646]
13. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358: 580-91. [PMID: 18256393] doi: 10.1056/NEJMoa0706245
14. Campbell SM, Roland MO, Buetow SA. Defining quality of care. Soc Sci Med. 2000;51: 1611-25. [PMID: 11072882]
15. Ahmann AJ. Guidelines and performance measures for diabetes. Am J Manag Care. 2007;13 Suppl 2: S41-6. [PMID: 17417932]
16. Pogach L, Aron DC. Sudden acceleration of diabetes quality measures. JAMA. 2011;305: 709-10. [PMID: 21325188] doi: 10.1001/jama.2011.153
17. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006;144: 465-74. [PMID: 16585660]
18. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291: 335-42. [PMID: 14734596]
19. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013; 368: 1613-24. [PMID: 23614587] doi: 10.1056/NEJMsa1213829
20. Centers for Disease Control and Prevention (CDC). Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep. 2011;60: 1618-23. [PMID: 22129997]
21. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52: 793-800. [PMID: 21367734] doi: 10.1093/cid/ciq243
22. Barr D, Hoover J, T. Horn. Revitalizing the U.S. national HIV/AIDS strategy. Harrington M, Benzacar A, eds. Washington, DC: Treatment Action Group; 2013. Accessed at www.treatmentactiongroup.org/sites/tagone .drupalgardens.com/files/201304/RevitalizeNHASMeetingReport.pdf on 10 October 2013.
23. Nosyk B, Montaner JS, Colley G, Lima VD, Chan K, Heath K, et al; STOP HIV/AIDS Study Group. The cascade of HIV care in British Columbia, Canada, 1996-2011: A population-based retrospective cohort study. Lancet Infect Dis. 2014;14: 40-9. [PMID: 24076277] doi: 10.1016/S1473-3099(13)70254-8
24. American Diabetes Association. Standards of medical care in diabetes- 2014. Diabetes Care. 2014;37 Suppl 1: S14-80. [PMID: 24357209] doi: 10.2337/dc14-S014
25. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311: 507-20. [PMID: 24352797] doi: 10.1001/jama.2013.284427
26. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129: S1-45. [PMID: 24222016] doi: 10.1161/01.cir.0000437738.63853.7a
27. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey: Questionnaires, datasets, and related documentation. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Accessed at www.cdc.gov/nchs/nhanes/nhanes-questionnaires.htm on 17 April 2014.
28. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey: 2007-2008 lab methods. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Accessed at www.cdc.gov/nchs/nhanes/nhanes2007-2008/lab-methods-07-08.htm on 17 April 2014.
29. Centers for Disease Control and Prevention, National Center for Health Statistics. Updated advisory for NHANES hemoglobin A1c (glycohemoglobin) data (revised March 2012). Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2012. Accessed at www.cdc.gov/nchs/data/nhanes/A1c-webnotice.pdf 17 April 2014.
30. Fryar CD, Chen TC, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010. NCHS Data Brief. 2012: 1-8. [PMID: 23101933]
31. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358: 2545-59. [PMID: 18539917] doi: 10.1056/NEJMoa0802743
32. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358: 2560-72. [PMID: 18539916] doi: 10.1056/NEJMoa0802987
33. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al; American Diabetes Association (ADA). Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35: 1364-79. [PMID: 22517736] doi: 10.2337/dc12-0413
34. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: Implications of recent clinical trials. Ann Intern Med. 2011;154: 554-9. [PMID: 21502652] doi: 10.7326/0003-4819-154-8-201104190-00007
35. U.S. Census Bureau Population Division. Methodology for the United States resident population estimates by age, sex, race, and Hispanic origin and the state and county total resident population estimates (vintage 2012): April 1, 2010 to July 1, 2012. Accessed at www.census.gov/popest/methodology/2012-nat-st-co-meth.pdf on 3 January 2014.
36. Bernstein J, Chollet D, Peterson S. How does insurance coverage improve health outcomes? Princeton, NJ: Mathematica Policy Research; 2010. Accessed at www.mathematica-mpr.com/publications/PDFs/health/reformhealthcare-IB1.pdf on 10 October 2013.
37. TRIAD Study Group. Health systems, patients factors, and quality of care for diabetes: A synthesis of findings from the TRIAD study. Diabetes Care. 2010; 33: 940-7. [PMID: 20351230] doi: 10.2337/dc09-1802
38. Gregg EW, Karter AJ, Gerzoff RB, Safford M, Brown AF, Tseng CW, et al. Characteristics of insured patients with persistent gaps in diabetes care services: The Translating Research into Action for Diabetes (TRIAD) study. Med Care. 2010;48: 31-7. [PMID: 20009778] doi: 10.1097/MLR.0b013e3181bd4783
39. Ettner SL, Thompson TJ, Stevens MR, Mangione CM, Kim C, Neil Steers W, et al; TRIAD Study Group. Are physician reimbursement strategies associated with processes of care and patient satisfaction for patients with diabetes in managed care? Health Serv Res. 2006;41: 1221-41. [PMID: 16899004]
40. U.S. Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148: 846-54. [PMID: 18519930]
41. Ratner RE. Diabetes management in the age of national health reform. Diabetes Care. 2011;34: 1054-7. [PMID: 21447668] doi: 10.2337/dc10-1987
42. Kelly E, Carls GS, Lenhart G, Mauceri E, Columbus D, Cavuoti A, et al. The Novartis health index: A method for valuing the economic impact of risk reduction in a workforce. J Occup Environ Med. 2010;52: 528-35. [PMID: 20431406] doi: 10.1097/JOM.0b013e3181dbe339
43. Rolando L, Byrne DW, McGown PW, Goetzel RZ, Elasy TA, Yarbrough MI. Health risk factor modification predicts incidence of diabetes in an employee population: Results of an 8-year longitudinal cohort study. J Occup Environ Med. 2013;55: 410-5. [PMID: 23532193] doi: 10.1097/JOM.0b013e31827cbaec
44. American Heart Association. Know your health numbers. Dallas, TX: American Heart Assoc; 2012. Accessed at www.heart.org/HEARTORG/Conditions/Diabetes/PreventionTreatmentofDiabetes/Know-Your-Health-Numbers-UCM-313882-Article.jsp on 17 April 2014.
45. American Diabetes Association. Are you at risk? Alexandria, VA: American Diabetes Assoc; 2014. Accessed at www.diabetes.org/are-you-at-risk on 17 April 2014.
46. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23: 588-94. [PMID: 18317847] doi: 10.1007/s11606-008-0554-8
47. Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: A systematic review and meta-analysis. Lancet. 2012;379: 2252-61. [PMID: 22683130] doi: 10.1016/S0140-6736(12)60480-2
48. Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev. 2001: CD001481. [PMID: 11279717]
49. Stellefson M, Dipnarine K, Stopka C. The chronic care model and diabetes management in US primary care settings: A systematic review. Prev Chronic Dis. 2013;10: E26. [PMID: 23428085] doi: 10.5888/pcd10.120180
50. MN Community Measurement. 2012 health care quality report. Minneapolis: MN Community Measurement; 2012. Accessed at http://mncm.org/wp-content/uploads/2013/04/2012-Final-HealthCareQualityReport-2.18.13.pdf on 10 November 2013.
51. Ofri D. Doctor priorities vs. patient priorities. New York Times. 27 March 2014. Accessed at http://well.blogs.nytimes.com/2014/03/27/doctor-priorities-vs-patient-priorities on 17 April 2014.
52. Martin SS, Blumenthal RS. Concepts and controversies: The 2013 American College of Cardiology/American Heart Association risk assessment and cholesterol treatment guidelines. Ann Intern Med. 2014;160: 356-8. [PMID: 24473832] doi: 10.7326/M13-2805
53. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group. BMJ. 1998;317: 720-6. [PMID: 9732339]
54. Gaede P, Valentine WJ, Palmer AJ, Tucker DM, Lammert M, Parving HH, et al. Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: Results and projections from the Steno-2 study. Diabetes Care. 2008;31: 1510-5. [PMID: 18443195] doi: 10.2337/dc07-2452
55. Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ. 2000;320: 1373-8. [PMID: 10818026]
56. Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the U.S.: The National Diabetes Prevention Program. Am J Prev Med. 2013;44: S346-51. [PMID: 23498297] doi: 10.1016/j.amepre.2012.12.009